Drugs Made In America Acquisition (DMAA) Free Cash Flow (2025)
Drugs Made In America Acquisition (DMAA) reported Free Cash Flow of -$125180.0 for Q4 2025, down 123.11% quarter-over-quarter from -$56108.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) Free Cash Flow (2025) Analysis & Trends
Drugs Made In America Acquisition has reported Free Cash Flow for 1 years, with the latest figure at -$125180.0 in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow changed N/A year-over-year to -$125180.0; the trailing twelve-month figure through Dec 2025 stood at -$539187.0 (changed N/A YoY), and the FY2025 full-year result was -$539187.0, down 213.0% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$125180.0, down from -$56108.0 in the prior quarter.
- The five-year high for Free Cash Flow was -$56108.0 in Q3 2025, with the low at -$251244.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -121,028.00 |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | -119,667.00 |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | -72,157.00 |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 10,832.00 |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -334,671.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -195,797.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | -171,240.00 |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | -1.42 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | -537,350.00 |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - | -125,180.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -125,180.00 |
| Dec 31, 2025 | -125,180.00 |
| Sep 30, 2025 | -56,108.00 |
| Sep 30, 2025 | -56,108.00 |
| Jun 30, 2025 | -106,655.00 |
| Jun 30, 2025 | -106,655.00 |
| Mar 31, 2025 | -251,244.00 |
| Mar 31, 2025 | -251,244.00 |